NEW YORK CITY, NY / ACCESS Newswire / August 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Telix Pharmaceuticals Limited ("Telix" or the "Company") (NASDAQ:TLX). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Telix and certain of its officers and/or […]
NEW YORK CITY, NY / ACCESS Newswire / August 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of agilon health, Inc. ("agilon" or the "Company") (NYSE:AGL). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether agilon and certain of its officers and/or
NEW YORK, NY / ACCESS Newswire / August 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Fortinet, Inc. ("Fortinet" or the "Company") (NASDAQ:FTNT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Fortinet and certain of its officers and/or directors have
NEW YORK CITY, NY / ACCESS Newswire / August 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of CPI Card Group Inc. ("CPI" or the "Company") (NASDAQ:PMTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether CPI and certain of its officers
NEW YORK CITY, NY / ACCESS Newswire / August 19, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed on behalf of investors in Easterly ROCMuni High Income Municipal Bond Fund f/k/a Principal Street High Income Municipal Fund ("the Fund" or the "Company") (NASDAQ:RMHIX; RMHVX; RMJAX). Such investors are advised to
NEW YORK CITY, NY / ACCESS Newswire / August 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of CPI Card Group Inc. ("CPI" or the "Company") (NASDAQ:PMTS). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether CPI and certain of its officers
NEW YORK CITY, NY / ACCESS Newswire / August 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation ("Neogen" or the "Company") (NASDAQ:NEOG). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether Neogen and certain of its officers and/or directors
NEW YORK CITY, NY / ACCESS Newswire / August 19, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Sarepta Therapeutics, Inc. ("Sarepta" or the "Company") (NASDAQ:SRPT). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are
NEW YORK CITY, NY / ACCESS Newswire / August 19, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Alto Neuroscience, Inc. ("Alto" or the "Company") (NYSE:ANRO) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-06105,
NEW YORK CITY, NY / ACCESS Newswire / August 19, 2025 / Pomerantz LLP announces that a class action lawsuit has been filed against Apple Inc. ("Apple" or the "Company") (NASDAQ:AAPL) and certain officers.�� The class action, filed in the United States District Court for the Northern District of California, and docketed under 25-cv-05197, is